🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Opaleye management purchases $438,902 in SANUWAVE Health shares

Published 11/01/2024, 07:50 PM
SNWVD
-

Opaleye Management Inc., a significant shareholder in SANUWAVE Health, Inc. (NASDAQ:SNWVD), has increased its stake in the company through a series of recent stock purchases. According to a recent SEC filing, Opaleye Management acquired a total of 27,868 shares of SANUWAVE Health common stock. These transactions, executed over several days, amounted to a total investment of $438,902.

The purchases were made at prices ranging from $15.1963 to $17.50 per share. Following these acquisitions, Opaleye Management now holds a substantial number of shares through direct and managed accounts. The transactions reflect Opaleye's ongoing investment interest in SANUWAVE Health, a company specializing in surgical and medical instruments.

This series of transactions highlights Opaleye Management's strategic positioning within SANUWAVE Health, as they continue to manage and expand their investment portfolio.

InvestingPro Insights

Opaleye Management's recent investment in SANUWAVE Health aligns with several key metrics and trends highlighted by InvestingPro. The company's stock has shown remarkable performance, with InvestingPro data indicating a 191.5% price total return over the past year and a staggering 225.13% year-to-date return. This strong performance is further underscored by the 153.48% return over the last three months, suggesting a significant upward momentum that may have attracted Opaleye's increased investment.

Despite the recent positive trajectory, an InvestingPro Tip notes that the stock has taken a big hit over the last week, with data showing a 9.43% decline. This recent dip might have presented a buying opportunity for Opaleye Management, potentially explaining the timing of their purchases.

SANUWAVE Health's financial metrics present a mixed picture. While the company boasts impressive revenue growth of 37.43% over the last twelve months, an InvestingPro Tip reveals that it is not profitable over the same period. This is reflected in the negative P/E ratio of -13.01 and a return on assets of -17.07%.

For investors seeking a more comprehensive analysis, InvestingPro offers 5 additional tips that could provide valuable insights into SANUWAVE Health's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.